Asthma Treatment




Asthma Treatment Reviews







Asthma Treatment Review


Sanofi's (SNY) Dupixent sBLA for Asthma Gets FDA Acceptance

The FDA accepts Sanofi's (SNY) sBLA for review of Dupixent for treating moderate-to-severe asthma in children aged six-11 years. A verdict from the FDA is expected on Oct 21, 2021.

Sanofi : FDA Accepts Dupixent For Review In Children With Moderate-to-severe Asthma

(REGN) and Sanofi said that the U.S. Food and Drug Administration has accepted for review the supplemental Biologics License Application or sBLA for Dupixent or dupilumab as an add-on treatment for ...

Uncontrolled asthma: a retrospective cohort study in Japanese patients newly prescribed with medium-/high-dose ICS/LABA

In order to understand the clinically meaningful response to ICS/LABA therapy in the Japanese population, we conducted a retrospective cohort study using the Japan Medical Data Centre (JMDC) Claims ...

Study: Asthma does not increase risk of severe illness or death from COVID-19

A new study looking at how COVID-19 affects people with asthma provides reassurance that having the condition doesn't increase the risk of severe illness or death from the virus.

Hospitalizations, ED Visits for COPD and Asthma Increase Under Certain Weather Conditions

Changes in temperature and atmospheric pressure were found to be associated with higher rates of medical care utilization for patients with chronic obstructive pulmonary disease (COPD) and asthma.


About Asthma Treatment


Sanofi's (SNY) Dupixent sBLA for Asthma Gets FDA Acceptance

The FDA accepts Sanofi's (SNY) sBLA for review of Dupixent for treating moderate-to-severe asthma in children aged six-11 years. A verdict from the FDA is expected on Oct 21, 2021.

Sanofi : FDA Accepts Dupixent For Review In Children With Moderate-to-severe Asthma

(REGN) and Sanofi said that the U.S. Food and Drug Administration has accepted for review the supplemental Biologics License Application or sBLA for Dupixent or dupilumab as an add-on treatment for ...

Uncontrolled asthma: a retrospective cohort study in Japanese patients newly prescribed with medium-/high-dose ICS/LABA

In order to understand the clinically meaningful response to ICS/LABA therapy in the Japanese population, we conducted a retrospective cohort study using the Japan Medical Data Centre (JMDC) Claims ...

Study: Asthma does not increase risk of severe illness or death from COVID-19

A new study looking at how COVID-19 affects people with asthma provides reassurance that having the condition doesn't increase the risk of severe illness or death from the virus.

Hospitalizations, ED Visits for COPD and Asthma Increase Under Certain Weather Conditions

Changes in temperature and atmospheric pressure were found to be associated with higher rates of medical care utilization for patients with chronic obstructive pulmonary disease (COPD) and asthma.


Asthma Treatment Buying Guide

Is poor indoor air quality making you sick?

But many of the things people do—or don’t do—can add to the stew of airborne contaminants in their homes and worsen asthma ... (See our air purifiers buying guide.) The ideal indoor relative ...

Treating asthma with inhaled steroids

If it does, that’s an indication that you have asthma. Asthma can usually be controlled with treatment. Most people with asthma lead normal active lives and having asthma doesn’t change how ...

Your Guide to Asthma Inhalers

Though the condition has no cure, an asthma specialist can help you manage ... who can help target your treatment based on your symptoms and blood, lung function and potentially other tests.

Treatment & Care

Asthma treatment can vary from inhalers to oral medications to drugs delivered in a nebulizer or breathing machine. Get a better understanding of how asthma medications work and learn about ...

Why there is no ‘one-size-fits-all’ treatment for asthma

Rather, as detailed in a new 54-page set of guidelines developed by an expert panel, in the 13 years since the last guidelines were issued, tremendous progress has been made in understanding the ...